Clinical Trials Directory

Trials / Conditions / Stage II Small Lymphocytic Lymphoma

Stage II Small Lymphocytic Lymphoma

7 registered clinical trials studyying Stage II Small Lymphocytic Lymphoma.

StatusTrialSponsorPhase
CompletedLenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphom
NCT02213913
University of ChicagoPhase 1 / Phase 2
TerminatedCyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leuk
NCT01076556
National Cancer Institute (NCI)Phase 1
CompletedOfatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia
NCT01024010
Mayo ClinicPhase 2
CompletedVorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untrea
NCT00918723
Fred Hutchinson Cancer CenterPhase 1 / Phase 2
CompletedDasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surg
NCT00608361
National Cancer Institute (NCI)Phase 1
TerminatedFenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
NCT00288067
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedTacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease i
NCT00105001
Fred Hutchinson Cancer CenterPhase 2